We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Daratumumab in Treatment of PGNMID and C3 GN, NCT03095118.
No takes yet. Share an insight, caveat, or question.
Zand et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: